InspireMD, Inc.

NSPR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12,708-$13,151-$11,166-$9,174
Dep. & Amort.$128$107$98$75
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,544$3,211$2,729$2,346
Change in WC$325$1,241-$540$336
Other Non-Cash$78$259$87-$333
Operating Cash Flow-$8,633-$8,333-$8,792-$6,750
Investing Activities
PP&E Inv.-$329-$576-$359-$311
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$4,840-$6,909$0
Inv. Sales/Matur.$7,888$10,760$9,000$0
Other Inv. Act.-$8-$22-$30$8,553
Investing Cash Flow$7,551$5,322$1,702$8,242
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$38,018$2,137$506$1,563
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$14,908$0$0$0
Financing Cash Flow$52,926$2,137$506$1,563
Forex Effect$50$0$51$43
Net Chg. in Cash$51,894-$874-$6,533$3,098
Supplemental Information
Beg. Cash$11,509$12,383$18,916$15,818
End Cash$63,403$11,509$12,383$18,916
Free Cash Flow-$8,962-$8,909-$9,151-$7,061
InspireMD, Inc. (NSPR) Financial Statements & Key Stats | AlphaPilot